Trilaciclib (trila) preserves and enhances immune system function in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy

被引：0
|
作者：
Sorrentino, J. A. [1 ]
Lai, A. [1 ]
Weiss, J. M. [2 ]
Dragnev, K. H. [3 ]
Owonikoko, T. K. [4 ]
Adler, S. [5 ]
Antal, J. M. [5 ]
Malik, R. K. [5 ]
Roberts, P. J. [1 ]
机构：
[1] G1 Therapeut Inc, Translat Med, Res Triangle Pk, NC USA
[2] Univ N Carolina, Hematol Oncol, Chapel Hill, NC 27515 USA
[3] Dartmouth Hitchcock Med Ctr, Hematol Oncol, Norris Cotton Canc Ctr, Lebanon, PA USA
[4] Emory Univ, Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[5] G1 Therapeut Inc, Clin Dev, Res Triangle Pk, NC USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1671P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis
    Long, Rong
    Chen, Fangping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Evaluation of Trilaciclib Use and Chemotherapy Induced Myelosuppression in Extensive-Stage Small Cell Lung Cancer
    Dela Cruz, F. A.
    Seetharamu, N.
    Kim, S.
    Aung, W. Y.
    Lee, C. -S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S666 - S666
  • [43] Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)
    Paz-Ares, L.
    Juan-Vidal, O.
    Carcereny, E.
    Greillier, L.
    Navarro, A.
    Bennouna, J.
    Santoro, A.
    Berardi, R.
    Besse, B.
    Salvagni, S.
    Gonzalez, H.
    de Alvaro, J.
    Parra-Palau, J.
    Sanchez-Perez, T.
    Aronchik, I.
    Filvaroff, E.
    Lamba, M.
    Nikolova, Z.
    Ponce, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S482 - S483
  • [44] Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
    Takahashi, T.
    Mori, K.
    Mizuno, R.
    Mamesaya, N.
    Kobayashi, H.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Naito, T.
    Murakami, H.
    Kenmotsu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1165 - S1165
  • [45] Updated safety and efficacy results of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC) from a phase II trial
    Chen, Dawei
    Gao, Aiqin
    Huang, Wei
    Shao, Qian
    Meng, Xiangjiao
    Tang, Xiaoyong
    Zhang, Pinliang
    Hu, Xudong
    Zhang, Yan
    Guo, Jun
    Fu, Lei
    Zhao, Wei
    Zhao, Changhong
    Yuan, Jiajia
    Yu, Jinming
    Wang, Linlin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] f Prophylactic cranial irradiation in patients with extensive-stage small-cell lung cancer (ES-SCLC): An updated tertiary cancer centre experience
    Naidoo, M.
    Lin, F.
    Jameson, M.
    Shelly, K.
    Srivastava, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 167 - 167
  • [47] Clinical efficacy of Camrelizumab combined with first-line chemotherapy in extensive-stage small-cell lung cancer
    Zhang, Dou
    Kong, Fanming
    Gao, Fangfang
    Li, Longhui
    Liang, Yangyueying
    Yu, Minghui
    Zhao, Lu
    Wang, Na
    Jia, Yingjie
    HELIYON, 2024, 10 (01)
  • [48] INTENSIVE CHEMOTHERAPY FOR EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC)
    OSOBA, D
    CANCER INVESTIGATION, 1992, 10 (02) : 185 - 186
  • [49] ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)
    Cheng, Y.
    Wang, J.
    Cang, S.
    Cao, L.
    Chen, E.
    Dong, X.
    Fan, Y.
    Gao, B.
    Guo, Q.
    Huang, D.
    Li, S.
    Liu, A.
    Lv, D.
    Pan, Y.
    Tang, K.
    Yao, W.
    Ye, F.
    Yu, Y.
    Zang, A.
    Gao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S727 - S728
  • [50] Efficacy and Safety of First-line Immunotherapy Plus Chemotherapy in Treating Elderly Patients With Extensive-stage Small Cell Lung Cancer
    Sonoda, M.
    Shinno, Y.
    Tamura, K.
    Yamaguchi, Y.
    Miyakoshi, J.
    Tateishi, A.
    Ikawa, Y.
    Torasawa, M.
    Shirasawa, M.
    Yoshida, T.
    Okuma, Y.
    Goto, Y.
    Horinouchi, H.
    Yamamoto, N.
    Ohe, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345